15 résultats
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a U.S. National Phase filing of International Application No. PCT/EP2013/068515, filed on Sep. 6, 2013, designating the United States of America and claiming priority to British Patent Application No. 1215950.5 filed Sep. 6, 2012 and
Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine.
Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening
Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine.
Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening
FIELD OF THE INVENTION
The present invention relates to a set of devices and a technique for treating headaches and particularly migraines.
DESCRIPTION OF THE RELATED ART
Severe headaches are suffered by large numbers of the American population. It is estimated that 1 in 10 males and 1 in 4 females
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be characterized by unilateral throbbing pain which worsens with head movement. This can be associated with other symptoms including nausea, light and noise sensitivity, lacrimation, nasal congestion, and rhinorrhea. An
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be characterized by unilateral throbbing pain which worsens with head movement. This can be associated with other symptoms including nausea, light and noise sensitivity, lacrimation, nasal congestion, and rhinorrhea. An
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be characterized by unilateral throbbing pain which worsens with head movement. This can be associated with other symptoms including nausea, light and noise sensitivity, lacrimation, nasal congestion, and rhinorrhea. An
FIELD OF THE INVENTION
The present invention generally relates to the use of botulinum toxin to treat pain, rhinorrhea or excessive lacrimation by targeting ganglion, such as the sphenopalatine ganglion, for example.
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be
FIELD OF THE INVENTION
The present invention generally relates to the use of botulinum toxin to treat pain, rhinorrhea or excessive lacrimation by targeting ganglion, such as the sphenopalatine ganglion, for example.
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be
FIELD OF THE INVENTION
The present invention generally relates to the use of botulinum toxin to treat pain, rhinorrhea or excessive lacrimation by targeting ganglion, such as the sphenopalatine ganglion, for example.
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be
FIELD OF THE INVENTION
The present invention generally relates to the use of botulinum toxin to treat pain, rhinorrhea or excessive lacrimation by targeting ganglion, such as the sphenopalatine ganglion, for example.
BACKGROUND OF THE INVENTION
Migraine is a primary headache disorder that may be
BACKGROUND OF THE INVENTION
The field of the present invention relates to the delivery of energy impulses (and/or energy fields) to bodily tissues for therapeutic purposes. The invention relates more specifically to the use of electrical stimulation of the sphenopalatine ganglion (SPG) and other
BACKGROUND OF THE INVENTION
The field of the present invention relates to the delivery of energy impulses (and/or energy fields) to bodily tissues for therapeutic purposes. The invention relates more specifically to the use of electrical stimulation of the sphenopalatine ganglion (SPG) and other
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT
N/A
RELATED APPLICATIONS
N/A
BACKGROUND OF THE DISCLOSURE
1. Field of the Disclosure
The present invention relates to methods, compositions and kits for treating frequent headaches. More particularly, this invention is concerned with
TECHNICAL FIELD
Embodiments disclosed herein generally relate to a method of treatment for weight-loss and other conditions in a mammal. More particularly, embodiments herein are directed to anatomically targeted, low-dosage delivery of antiepileptic/anticonvulsant compounds for weight-loss and